Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.

A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with pediatric allogeneic ...

CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company") today released a letter to shareholders from the Chairman of the Company's Board ...

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with ...

CytoMed has generated the critical cell banks for the iPSC-derived hybrid of gamma delta T and Natural Killer cell technology and is currently undergoing process development into a potentially very ...

EQS-News: Vita 34 AG / Key word (s): Legal Matter/Miscellaneous Vita 34 AG strengthens its international brand presence by change of name to FamiCord AG 06.02.2025 / 07:30 CET/CEST The issuer is ...

Cord blood banking involves collecting blood left in your newborn's umbilical cord and placenta and storing it for future ...

The global cell separation market size was valued at USD 9.74 billion in 2024 and is projected to reach from USD 10.69 ...

"With the global stem cell market expanding, we see an opportunity to make these treatments more accessible in the U.S.," ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell treatments to desperate patients looking for cures of intractable diseases and ...